July 2023

For many patients with C diff, the experience of medical gaslighting is a common one because many health care providers lack education and familiarity with the disease.

Specialty pharmacists can have more contact with patients than providers.

Pharmacist-led discharge stewardship initiatives have shown promising results.

FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.

Drug shortages have led to increased use of compounding pharmacy.

Quality standards and national regulation help to establish its role as medicine.

Data show these cases pose some of the most significant threats to patients and health systems.

Renewed focus on the potential this drug can provide patients is upon us as we continue to strive for greater and better care and treatment for patients throughout US health systems.

We all have an interest in reducing harm and deaths from opiates and other controlled substances, but we should have evidence-based and patient-centered approaches that do not have unintended consequences on patient health and safety.